Table of Content - Infertility Market Size, Growth, Trends, Report 2032

Infertility Market Segmentation

Infertility Sex Outlook (USD Billion, 2019-2030)

Males

Females

Unexplained

Infertility Diagnosis Outlook (USD Billion, 2019-2030)

Men Diagnostic Tests

Women Diagnostic Tests

General Diagnostic Test

Infertility Drugs Outlook (USD Billion, 2019-2030)

Clomiphene Citrate

Letrozole

Serophene

Hormone Treatment

Others

Infertility Technology Outlook (USD Billion, 2019-2030)

Assisted Reproductive Technology

Intrauterine Insemination

Surgery

Infertility Regional Outlook (USD Billion, 2019-2030)

North America Outlook (USD Billion, 2019-2030)
- North America Infertility by Sex
  - Males
  - Females
  - Unexplained
- North America Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- North America Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- North America Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- US Outlook (USD Billion, 2019-2030)
- US Infertility by Sex
  - Males
  - Females
  - Unexplained
- US Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- US Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- US Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- CANADA Outlook (USD Billion, 2019-2030)
- CANADA Infertility by Sex
  - Males
  - Females
  - Unexplained
- CANADA Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- CANADA Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- CANADA Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery

Europe Outlook (USD Billion, 2019-2030)
- Europe Infertility by Sex
  - Males
  - Females
  - Unexplained
- Europe Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Europe Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Europe Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- Germany Outlook (USD Billion, 2019-2030)
- Germany Infertility by Sex
  - Males
  - Females
  - Unexplained
- Germany Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Germany Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Germany Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- France Outlook (USD Billion, 2019-2030)
- France Infertility by Sex
  - Males
  - Females
  - Unexplained
- France Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- France Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- France Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- UK Outlook (USD Billion, 2019-2030)
- UK Infertility by Sex
  - Males
  - Females
  - Unexplained
- UK Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- UK Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole Serophene
  - Hormone Treatment
  - Others
- UK Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- ITALY Outlook (USD Billion, 2019-2030)
- ITALY Infertility by Sex
  - Males
  - Females
  - Unexplained
- ITALY Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- ITALY Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- ITALY Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery

SPAIN Outlook (USD Billion, 2019-2030)

Spain Infertility by Sex
- Males
- Females
- Unexplained

Spain Infertility by Diagnosis
- Men Diagnostic Tests
- Women Diagnostic Tests
- General Diagnostic Test

Spain Infertility by Drugs
- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others

Spain Infertility by Technology
- Assisted Reproductive Technology
- Intrauterine Insemination
- Surgery

Rest Of Europe Outlook (USD Billion, 2019-2030)

Rest Of Europe Infertility by Sex
- Males
- Females
- Unexplained

REST OF EUROPE Infertility by Diagnosis
- Men Diagnostic Tests
- Women Diagnostic Tests
- General Diagnostic Test

REST OF EUROPE Infertility by Drugs
- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others

REST OF EUROPE Infertility by Technology
- Assisted Reproductive Technology
- Intrauterine Insemination
- Surgery

Asia-Pacific Outlook (USD Billion, 2019-2030)
- Asia-Pacific Infertility by Sex
  - Males
  - Females
  - Unexplained
- Asia-Pacific Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Asia-Pacific Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Asia-Pacific Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- China Outlook (USD Billion, 2019-2030)
- China Infertility by Sex
  - Males
  - Females
  - Unexplained
- China Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- China Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- China Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- Japan Outlook (USD Billion, 2019-2030)
- Japan Infertility by Sex
  - Males
  - Females
  - Unexplained
- Japan Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Japan Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Japan Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- India Outlook (USD Billion, 2019-2030)
- India Infertility by Sex
  - Males
  - Females
  - Unexplained
- India Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- India Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- India Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- Australia Outlook (USD Billion, 2019-2030)
- Australia Infertility by Sex
  - Males
  - Females
  - Unexplained
- Australia Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Australia Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Australia Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery
- Rest of Asia-Pacific Outlook (USD Billion, 2019-2030)
- Rest of Asia-Pacific Infertility by Sex
  - Males
  - Females
  - Unexplained
- Rest of Asia-Pacific Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Rest of Asia-Pacific Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Rest of Asia-Pacific Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery

Rest of the World Outlook (USD Billion, 2019-2030)
- Rest of the World Infertility by Sex
  - Males
  - Females
  - Unexplained
- Rest of the World Infertility by Diagnosis
  - Men Diagnostic Tests
  - Women Diagnostic Tests
  - General Diagnostic Test
- Rest of the World Infertility by Drugs
  - Clomiphene Citrate
  - Letrozole
  - Serophene
  - Hormone Treatment
  - Others
- Rest of the World Infertility by Technology
  - Assisted Reproductive Technology
  - Intrauterine Insemination
  - Surgery

Middle East Outlook (USD Billion, 2019-2030)

Middle East Infertility by Sex
- Males
- Females
- Unexplained

Middle East Infertility by Diagnosis
- Men Diagnostic Tests
- Women Diagnostic Tests
- General Diagnostic Test

Middle East Infertility by Drugs
- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others

Middle East Infertility by Technology
- Assisted Reproductive Technology
- Intrauterine Insemination
- Surgery

Africa Outlook (USD Billion, 2019-2030)

Africa Infertility by Sex
- Males
- Females
- Unexplained

Africa Infertility by Diagnosis
- Men Diagnostic Tests
- Women Diagnostic Tests
- General Diagnostic Test

Africa Infertility by Drugs
- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others

Africa Infertility by Technology
- Assisted Reproductive Technology
- Intrauterine Insemination
- Surgery

Latin America Outlook (USD Billion, 2019-2030)

Latin America Infertility by Sex
- Males
- Females
- Unexplained

Latin America Infertility by Diagnosis
- Men Diagnostic Tests
- Women Diagnostic Tests
- General Diagnostic Test

Latin America Infertility by Drugs
- Clomiphene Citrate
- Letrozole
- Serophene
- Hormone Treatment
- Others

Latin America Infertility by Technology
- Assisted Reproductive Technology
- Intrauterine Insemination
- Surgery

Research Methodology on Infertility Market

Executive Summary

This study aims to review the Infertility Market, a sub-category of the reproductive healthcare market. The report offers a comprehensive view of current and future market trends in infertility treatments and interviews with healthcare practitioners to gain insights into the current market conditions.

1. Introduction

The Market Research Future is an agency that provides reports related to different industries such as healthcare, pharmaceutical, lifestyle and others. This particular report focuses on the Infertility Market, one of the most significant components of the reproductive healthcare market. The infertility Market has witnessed an increase in demand over the past years that is expected to continue to grow from 2023 to 2030.

2. Objectives of the Study

The main objective of this research is to understand the latest market trends in the Infertility Market while exploring and providing an in-depth analysis of the market data, to better understand the current state of the market and eventual market conditions. The project intends to provide an overview of the current market dynamics of the Infertility Market and gain insight into the market size and forecast for the upcoming years. In detail, the research project aims to provide the following:

A comprehensive market analysis of the infertility treatments

An analysis of current and emerging market trends

A study of current market size and forecast market growth

Results of interviews with leading healthcare practitioners

An evaluation of government policies, regulations and initiatives

Analyse the effect of key drivers in the market

Geographical and industry analysis

3. Methodology

The research methodology used in the report is based on a mix of secondary and primary data sources. The methods used in the initial research stage included e-mail surveys and interviews with leading health practitioners. The primary data collected is used to validate the secondary data sources and to maintain consistency with the other sources. Data related to market size and value, market segmentation, and other industry information was sourced from both published sources and industry databases.

In addition to the primary and secondary research methods, research is also conducted through desk research and data mining techniques. The data obtained through the methods are used to create models for the analysis of the market size and trends. The data gathered from the sources is collected in a database and used to explore in-depth market analysis. This includes an analysis of market dynamics, market segments, and current and upcoming trends.

4. Scope of the Study

This report covers the market performance of infertility treatments in the global market. The geographical regions that are included in the study are Europe, North America, Asia-Pacific, Latin America, and the Middle East. Furthermore, the study considers the market conditions and industry trends. Additionally, the report covers the market size and forecasts for infertility treatments, recent government policies and initiatives, and an analysis of the current market environment.

5. Conclusion

This research is conducted to gain a better understanding of the Infertility Market and trends. The primary and secondary research methods used in this report have revealed trends and details of the current market dynamics and market size. Current market trends suggest a significant increase in the demand for infertility treatments over the past years.

Furthermore, the research revealed that healthcare practitioners are looking to provide a more comprehensive approach to treating infertility and the current government policies and initiatives are likely to facilitate the growth of the market. The research is expected to benefit the market players and provide them with the necessary information to make informed decisions in the future.

Leading companies partner with us for data-driven Insights

Please fill in Business Email for Quick Response

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

TABLE OF CONTENTS

1. EXECUTIVE SUMMARY

1.1. Market Attractiveness Analysis

1.1.1. Global Infertility Market, by Patient Type

1.1.2. Global Infertility Market, by Diagnosis

1.1.3. Global Infertility Market, by Drug

1.1.4. Global Infertility Market, by Technique

1.1.5. Global Infertility Market, by End User

1.1.6. Global Infertility Market, by Region

2. MARKET INTRODUCTION

2.1. Definition

2.2. Scope of the Study

2.3. Market Structure

3. RESEARCH METHODOLOGY

3.1. Overview

3.2. Data Mining

3.3. Secondary Research

3.4. Primary Research

3.4.1. Primary Interviews and Information Gathering Process

3.4.2. Breakdown of Primary Respondents

3.5. Forecasting Techniques

3.6. Market Size Estimation

3.6.1. Bottom-Up Approach

3.6.2. Top-Down Approach

3.7. Data Triangulation

3.8. Validation

4. MARKET DYNAMICS

4.1. Overview

4.2. Drivers

4.2.1. Declining fertility rate

4.2.2. Technological advancements

4.2.3. XXXX

4.3. Restraints

4.3.1. Less awareness about new technologies

4.3.2. XXXX

4.4. Opportunities

4.4.1. XXXX

5. MARKET FACTOR ANALYSIS

5.1. Value Chain Analysis

5.2. Porter’s Five Forces Model

5.2.1. Bargaining Power of Suppliers

5.2.2. Bargaining Power of Buyers

5.2.3. Threat of New Entrants

5.2.4. Threat of Substitutes

5.2.5. Intensity of Rivalry

5.3. Covid-19 Impact Analysis

5.3.1. Impact on the Growth of the Market

5.3.2. Impact on Pricing

5.3.3. Opportunity Analysis

5.3.4. Import and Export Impact

6. GLOBAL INFERTILITY MARKET, BY PATIENT TYPE

6.1. Overview

6.2. Male

6.3. Female

6.4. Unexplained

7. GLOBAL INFERTILITY MARKET, BY DIAGNOSIS

7.1. Overview

7.2. Men Diagnostic Tests

7.2.1. Semen Analysis

7.2.2. Genetic Testing

7.2.3. Testicular Biopsy

7.2.4. Others

7.3. Women Diagnostic Tests

7.3.1. Hysteroscopy

7.3.2. Laparoscopy

7.3.3. Ovulation Testing

7.3.4. Others

7.4. General Diagnostic Tests

7.4.1. Genetic Testing

7.4.2. Hormone Testing

7.4.3. Microscopic Analysis

7.4.4. Imaging

7.4.5. Others

8. GLOBAL INFERTILITY MARKET, BY DRUG

8.1. Overview

8.2. Clomiphene Citrate

8.3. Letrozole

8.4. Serophene

8.5. Hormone Treatment

8.6. Others

9. GLOBAL INFERTILITY MARKET, BY TECHNIQUE

9.1. Overview

9.2. Assisted Reproductive Technology (ART)

9.3. Intrauterine Insemination

9.4. Tubal Surgery

9.5. Others

10. GLOBAL INFERTILITY MARKET, BY END USER

10.1. Overview

10.2. Hospitals and Clinics

10.3. Fertility Centers

10.4. Others

11. GLOBAL INFERTILITY MARKET, BY REGION

11.1. Overview

11.2. North America

11.2.1. US

11.2.2. Canada

11.3. Europe

11.3.1. Germany

11.3.2. France

11.3.3. UK

11.3.4. Italy

11.3.5. Spain

11.3.6. Rest of Europe

11.4. Asia-Pacific

11.4.1. China

11.4.2. India

11.4.3. Japan

11.4.4. South Korea

11.4.5. Australia

11.4.6. Rest of Asia-Pacific

11.5. Rest of the World

11.5.1. Middle East

11.5.2. Africa

11.5.3. Latin America

12. COMPETITIVE LANDSCAPE

12.1. Overview

12.2. Competitive Analysis

12.3. Market Share Analysis

12.4. Major Growth Strategy in the Global Infertility Market

12.5. Competitive Benchmarking

12.6. Leading Player in terms of Number of Developments in Global Infertility Market

12.7. Key Developments & Growth Strategies

12.7.1. New Product Launch

12.7.2. Merger & Acquisition

12.7.3. Joint Ventures

12.8. Major Players Financial

12.8.1. Sales & Operating Income 2021

12.8.2. Major Players R&D Expenditure 2021

13. COMPANY PROFILES

13.1. Olympus Corporation

13.1.1. Company Overview

13.1.2. Financial Overview

13.1.3. Products Offered

13.1.4. Key Developments

13.1.5. SWOT Analysis

13.1.6. Key Strategies

13.2. CooperSurgical, Inc.

13.3. Virtus Health

13.4. Vitrolife

13.5. INVO Bioscience

13.6. Monash IVF

13.7. Genea Limited

13.8. Merck KGaA

13.9. Thermo Fisher Scientific

13.10. Esco Medical

13.11. Rocket Medical plc

13.12. Medgyn Products

13.13. Others

14. APPENDIX

14.1. References

14.2. Related Reports

NOTE:

This table of content is tentative and subject to change as the research progresses.

 In section 13, only top 10 companies will be profiled. Each company will be profiled based on the Market Overview, Financials, Service Portfolio, Business Strategies, and Recent Developments parameters.

 In Section 13, the SWOT will be provided for top 5 companies.

 Please note: The financial details of the company cannot be provided if the information is not available in the public domain and rom reliable sources.

Purchase Option
	Single User	$ 4,950
	Multiuser License	$ 5,950
	Enterprise User	$ 7,250
Compare Licenses

FEATURES	LICENCE TYPE
FEATURES	Single User	Multiuser Licence	Enterprise User
Price	$ 4,950	$ 5,950	$ 7,250
Maximum User Access Limit	1 User	Upto 10 Users	Unrestricted Access Throughout The Organization.
Free Customization
Direct access to the Analyst
Deliverable Format
Deliverable Format
Platform Access
Discount on Your Next Purchase	10%	15%	10%
Printable Versions

Certified Global Research Member

Key Questions Answered

Why Choose Market Research Future?

Leading companies partner with us for data-driven Insights

Tailored for You